Framlington Nasdaq Fund

Framlington Nasdaq Fund. 2005-02-01

The Nasdaq: Due for a rebound?

Since its meteoric rise in 1999 and its subsequent nose dive in 2000, the Nasdaq has failed to turn in consistent up ward momentum.

We have had a long association with Framlington fund management since our days of working in the city of London.

We have invested in the Framlington Health fund a number of times in the past and made great profits on each occasion.
We feel that the Nasdaq is due for a rebound this year and we like the current share holdings that the Framlington Nasdaq fund has.
This fund will give you exposure to the Nasdaq and will benefit from any upward movements.
 
The broad aim of the fund is :To provide long term capital growth by principally investing in companies listed on The Nasdaq Stock Market®.

Investment is made in companies which, in the Manager's opinion, show above average profitability, management quality and growth.

Nasdaq® Fund
   
     TOP TEN HOLDINGS   

    Intel Corporation   

    Marvell Technology Group   

    Checkfree Holdings Corpn   

    Monster Worldwide   

    Amgen   

    Microsoft Corporation   

    Paychex   

    Apple Computer   

    Yahoo!   

    eBay   


             SECTOR SPLIT    %

    Information technology    71.2

    Healthcare    13.5

    Consumer discretionary    7.7

    Industrials    4.4

    Financials    1.8

    Cash    1.4


             REGIONAL SPLIT    %

    North America    87.1

    Europe Ex UK    7.3

    Africa / M. East 2.4

    UK    1.8

    Cash    1.4


Framlington International Portfolios (FIP) provides international investors with an efficient way of accessing the most profitable investment areas.
The range of FIP funds covers exciting high growth sectors and markets such as healthcare and technology.  
FIP is an open-ended Luxembourg umbrella fund, established as a société d'investissement à capital variable (SICAV).
It benefits from UCITS status in the UK and Europe.

Buy The Framlington Nasdaq Fund up to US$ 14.50